GlaxoSmithKline PLC Director/PDMR Shareholding (9208J)
16 Abril 2020 - 7:49AM
UK Regulatory
TIDMGSK
RNS Number : 9208J
GlaxoSmithKline PLC
16 April 2020
GlaxoSmithKline plc (the ' Company ')
Transaction notification
1. Details of PDMR/person closely associated with them
('PCA')
=====================================================================
a) Name Ms V Whyte
=== ======================== ===========================================
b) Position/status Company Secretary
=== ======================== ===========================================
c) Initial notification/ Initial notification
amendment
=== ======================== ===========================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== =====================================================================
a) Name GlaxoSmithKline plc
=== ======================== ===========================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ===========================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== =====================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ======================== ===========================================
b) Nature of the Acquisition of Ordinary Shares following
transaction the re-investment of dividends paid to
shareholders on 9 April 2020, on Ordinary
Shares held within an ISA.
=== ======================== ===========================================
c) Price(s) and Price(s) Volume(s)
volume(s) ----------
GBP15.6582 26
----------
=== ======================== ===========================================
d) Aggregated information N/A (single transaction)
Aggregated volume
Price
=== ======================== ===========================================
e) Date of the transaction 2020-04-14
=== ======================== ===========================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ======================== ===========================================
1. Details of PDMR/person closely associated with them
('PCA')
=====================================================================
a) Name Mr D Redfern
=== ======================== ===========================================
b) Position/status Chief Strategy Officer
=== ======================== ===========================================
c) Initial notification/ Initial notification
amendment
=== ======================== ===========================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== =====================================================================
a) Name GlaxoSmithKline plc
=== ======================== ===========================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ===========================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== =====================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ======================== ===========================================
b) Nature of the Acquisition of Ordinary Shares following
transaction the re-investment of dividends paid to
shareholders on 9 April 2020, on Ordinary
Shares held within an ISA.
=== ======================== ===========================================
c) Price(s) and Price(s) Volume(s)
volume(s) ----------
GBP15.6582 30
----------
=== ======================== ===========================================
d) Aggregated information N/A (single transaction)
Aggregated volume
Price
=== ======================== ===========================================
e) Date of the transaction 2020-04-14
=== ======================== ===========================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ======================== ===========================================
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
DSHLQLFFBZLZBBD
(END) Dow Jones Newswires
April 16, 2020 08:49 ET (12:49 GMT)
Gsk (LSE:GSK)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Gsk (LSE:GSK)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024